Yahoo
TSXV - Delayed Quote CAD

Ventripoint Diagnostics Ltd. (VPT.V)

0.0800 0.0000 (0.00%)
At close: October 30 at 3:52:35 PM EDT
Chart Range Bar
Loading chart for VPT.V
  • Previous Close 0.0800
  • Open 0.0800
  • Bid 0.0750 x --
  • Ask 0.0800 x --
  • Day's Range 0.0750 - 0.0800
  • 52 Week Range 0.0750 - 0.1900
  • Volume 259,484
  • Avg. Volume 126,483
  • Market Cap (intraday) 15.43M
  • Beta (5Y Monthly) 0.09
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date (est.) Nov 26, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.

ventripoint.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

VPT.V
33.33%
S&P/TSX Composite index (^GSPTSE)
11.78%

1-Year Return

VPT.V
27.27%
S&P/TSX Composite index (^GSPTSE)
18.03%

3-Year Return

VPT.V
55.56%
S&P/TSX Composite index (^GSPTSE)
88.90%

5-Year Return

VPT.V
84.00%
S&P/TSX Composite index (^GSPTSE)
69.32%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -263.57%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    147.77k

  • Net Income Avi to Common (ttm)

    -2.32M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    333.63k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -2.41M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: